Mercado de segunda opinión médica: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00011728
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 158
Buy Now

Se espera que el mercado de segunda opinión médica alcance los 10.739,48 millones de dólares en 2027, frente a los 3.204,57 millones de dólares de 2019; se estima que crecerá a una tasa compuesta anual del 16,8% de 2020 a 2027.
La segunda opinión médica tiene como objetivo proporcionar información valiosa sobre las opciones de tratamiento actuales del paciente. El concepto juega un papel importante a la hora de abordar la confusión creada por la recomendación de varias alternativas de tratamiento para un solo caso. Además, también se busca la opinión para obtener información adicional que pueda ser útil para mejorar los resultados del tratamiento de una enfermedad. La segunda opinión médica puede validar el diagnóstico; por lo tanto, juega un papel importante en el aumento de la precisión del tratamiento. El mercado mundial de segunda opinión médica está impulsado por factores como resultados superiores del tratamiento y una creciente preferencia por la optimización de los costos de atención médica. Sin embargo, la falta de conciencia y la renuencia a optar por una segunda opinión médica en los países emergentes obstaculizan el crecimiento del mercado. Además, las crecientes inversiones en tecnologías de telemedicina están creando oportunidades de crecimiento para los actores del mercado.

Mercados regionales lucrativos para la segunda opinión médica

Perspectivas del mercado

Creciente preferencia por la optimización de los costos de atención médica

Los pacientes de todo el mundo son testigos de crecientes cargas financieras impuestas por los servicios de atención médica. Los crecientes costos asociados a la atención médica debido a la escasez general de profesionales de la salud y la disponibilidad limitada de recursos están generando la necesidad de optimizar los costos de la atención médica en todo el mundo. Además, el creciente énfasis en la reducción de costos adicionales y la mayor conciencia sobre la posible explotación por parte de las organizaciones de atención médica, especialmente en países de ingresos bajos y medios, impulsan significativamente el mercado de la segunda opinión médica. Los consumidores pueden aprovechar amplia información de segundas opiniones médicas mientras toman las decisiones necesarias sobre la cirugía o el caso principal. Además, los proveedores de segunda opinión médica revisan las recomendaciones para procedimientos quirúrgicos sobre la base de diagnósticos médicos adicionales, análisis de registros médicos existentes y evaluación de otras soluciones terapéuticas como alternativa a la cirugía. Estos aspectos de la segunda opinión pueden resultar en una reducción del costo terapéutico. Además, una segunda opinión sobre decisiones quirúrgicas también puede dar como resultado una reducción de posibles adversidades quirúrgicas, lo que puede generar costos adicionales relacionados con la atención médica.

Por ejemplo, según un estudio publicado por la Organización Mundial de la Salud en 2019, ~25,0% de los pacientes en todo el mundo sufren complicaciones en los procedimientos quirúrgicos. Además, aproximadamente 1 millón de personas mueren durante la cirugía o durante el seguimiento de la misma cada año.

El creciente número de errores en la facturación médica es también uno de los factores destacados responsables del crecimiento del mercado. Por ejemplo, según un estudio publicado por Medical Billing Advocates of America en 2019, se estima que el 80,0 % de las facturas médicas contienen al menos un error. Además, los problemas de errores de facturación médica cuestan un total de ~210 mil millones de dólares cada año en Estados Unidos. Se prevé que estas posibilidades y ocurrencia de errores financieros acelerarán el crecimiento del mercado de segunda opinión médica para 2027.
 

Información basada en trastornos

Basado en trastornos, El mercado de segunda opinión médica se segmenta en cáncer, diabetes, trastornos cardíacos, trastornos neurológicos, trastornos nefrológicos, trastornos hematológicos, EPOC, trastornos ortopédicos, trasplantes de órganos y otras enfermedades. En 2019, el segmento del cáncer representó la mayor parte del mercado mundial de segunda opinión médica. El crecimiento del mercado para este segmento se atribuye a la creciente prevalencia del cáncer y a la creciente preferencia por una segunda opinión para el diagnóstico y tratamiento del cáncer.

Mercado global de segunda opinión médica, por trastornos: 2018 y 2027

Información basada en proveedores de servicios

Según el proveedor de servicios, el mercado de segunda opinión médica es segmentado en hospitales, compañías de seguros de salud y servicios en línea. El segmento de hospitales tuvo la mayor participación del mercado en 2019; sin embargo, se espera que el mercado de servicios en línea crezca a la CAGR más alta durante el período de pronóstico.

Información estratégica

Lanzamientos y aprobaciones de productos son las estrategias comúnmente adoptadas por las empresas para expandir su huella global y sus carteras de productos; estas estrategias les ayudan a satisfacer la creciente demanda de los consumidores. La colaboración es una de las principales estrategias adoptadas por los actores del mercado de segunda opinión médica para ampliar la base de clientes en todo el mundo, lo que también les permite mantener su marca a nivel mundial.

Global Medical Mercado de segunda opinión: Por trastorno

  • Cáncer
  • Ortopédico
  • Trastornos cardíacos
  • Trastornos neurológicos
  • Trastornos nefrológicos
  • Trastornos hematológicos de la sangre
  • EPOC
  • Trasplante de órganos
  • Otros

Mercado mundial de segunda opinión médica y ndash ; Por proveedor de servicios

  • Hospitales
  • Compañías de seguros médicos
  • Servicios en línea

Mercado de segunda opinión médica: Por geografía

  • América del Norte
    • Estados Unidos
    • Canadá
    • México
  • < li>Europa
    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • Resto de Europa
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
    • Resto de Oriente Medio y África
  • Sur y Centroamérica
    • Brasil
    • Argentina
    • Resto de Sudamérica

 < /p>

Perfiles de empresas

  • Medisense Healthcare Solutions Pvt. Limitado. Ltd.
  • Second Opinion International
  • Servicios médicos de élite
  • Cigna
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • Medix
  • 2nd.MD
  • AXA
  • Teladoc Health, Inc
  • DoctorSpring Pvt. Limitado. Ltd
  • USARAD Holdings Inc (SecondOpinions.com)
  • Clínica Cleveland
  • Grand Rounds, Inc.
  • Mass General Brigham Incorporated. (Partners Healthcare)
  • Stanford Health Care
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is medical second opinion?

Medical second opinion is intended to provide valuable information about the patient’s current treatment options. The concept plays a significant role in dealing with the confusion created through the recommendation of various treatment alternatives for a single case. Besides, the opinion is also sought to gain additional information, which can be helpful to improve treatment outcomes of a disease. The medical second opinion can validate diagnosis; thus, it plays a major role in increasing the accuracy of the treatment.

What are the driving factors for the medical second opinion market across the globe?

The factors that are driving growth of the market are growing emphasis on superior treatment outcomes and increasing preference for healthcare cost optimization. Moreover, strategic activities by the technological companies to boost telemedicine technologies are offering lucrative opportunities for the growth of the market.

Who are the major players in the medical second opinion market?

The medical second opinion market majorly consists of the players such as Medisense Healthcare Solutions Pvt. Ltd., Second Opinion International, Elite Medical Services, Cigna, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, Medix, 2nd.MD, and AXA amongst others.

The List of Companies - Medical Second Opinion Market

  1. Medisense Healthcare Solutions Pvt. Ltd.
  2. Second Opinion International
  3. Elite Medical Services
  4. Cigna
  5. Helsana
  6. WorldCare
  7. Vidal Health Insurance TPA Pvt Ltd
  8. Medix
  9. 2nd.MD
  10. AXA
  11. Teladoc Health, Inc
  12. DoctorSpring Pvt. Ltd
  13. USARAD Holdings Inc (SecondOpinions.com)
  14. Cleveland Clinic
  15. Grand Rounds, Inc.
  16. Mass General Brigham Incorporated. (Partners Healthcare)
  17. Stanford Health Care

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports